ID
26729
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Liver events
Keywords
Versions (5)
- 10/11/17 10/11/17 -
- 10/16/17 10/16/17 -
- 10/16/17 10/16/17 -
- 10/23/17 10/23/17 -
- 1/11/18 1/11/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 23, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Liver events GSK study Chronic Coronary Heart Disease NCT00799903
Liver events GSK study Chronic Coronary Heart Disease NCT00799903
Description
Liver events
Description
subject age
Data type
boolean
Description
If yes, ensure Pregnancy Notification Form has been completed.
Data type
text
Description
diagnostic imaging of liver or hepatobiliary system
Data type
boolean
Description
If No, record the details on the Non-Serious Adverse Events form or Serious Adverse Event form.
Data type
boolean
Description
If yes, complete Liver Biopsy form.
Data type
boolean
Description
If yes, record on the appropriate Concomitant Medication form.
Data type
boolean
Description
dietary change
Data type
boolean
Description
[hidden]
Data type
text